Loading ticker data...
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| 2025-01-22 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 865 | $18.94 | $16,383.88 | -1.2% | → |
| 2025-01-22 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sell | 2,437 | $19.46 | $47,424.02 | -3.1% | → |
| 2025-01-22 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 10,736 | $19.46 | $208,922.56 | -3.0% | → |
| 2025-01-22 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 925 | $18.94 | $17,520.24 | -1.7% | → |
| 2025-01-06 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | 2,506 | $19.04 | $47,715.00 | -2.1% | → |
| 2024-12-26 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale+OE | 15,000 | $17.22 | $258,277.50 | -21.5% | → |
| 2024-11-25 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sale+OE | 12,090 | $18.30 | $221,257.88 | -18.0% | → |
| 2024-10-04 | LYONS GARY A | - | Sale+OE | 40,000 | $14.73 | $589,100.78 | -24.9% | → |
| 2024-09-30 | Meckler Jeffrey A | - | Sale+OE | 40,000 | $14.06 | $562,324.00 | -33.1% | → |
| 2024-09-10 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | 684 | $12.98 | $8,878.32 | -1.1% | → |
| 2024-09-09 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 21,125 | $11.52 | $243,360.00 | -5.5% | → |
| 2024-09-09 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 2,490 | $11.52 | $28,684.80 | -3.2% | → |
| 2024-09-09 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sell | 4,387 | $11.52 | $50,538.24 | -5.3% | → |
| 2024-09-09 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Sell | 2,191 | $11.52 | $25,240.32 | -2.0% | → |
| 2024-09-09 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sell | 4,387 | $11.52 | $50,538.24 | -4.9% | → |
| 2024-09-09 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | 2,191 | $11.52 | $25,240.32 | -3.4% | → |
| 2024-09-04 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 514 | $9.51 | $4,887.78 | -0.7% | → |
| 2024-04-11 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 54 | $6.74 | $363.96 | - | → |
| 2024-02-01 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 19,122 | $8.70 | $166,435.06 | -2.6% | → |
| 2024-02-01 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 3,818 | $8.53 | $32,572.50 | -5.1% | → |
| 2024-02-01 | Inrig Jula | CHIEF MEDICAL OFFICER | Sell | 2,174 | $8.53 | $18,546.61 | -3.6% | → |
| 2024-02-01 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Sell | 4,195 | $8.53 | $35,788.80 | -4.0% | → |
| 2024-02-01 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sell | 4,764 | $8.71 | $41,495.32 | -3.0% | → |
| 2024-02-01 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 2,820 | $8.53 | $24,057.98 | -5.1% | → |
| 2024-02-01 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sell | 4,764 | $8.71 | $41,495.10 | -2.8% | → |
| 2024-01-23 | REED ELIZABETH E | SVP, GC & CORPORATE SECRETARY | Sell | 2,062 | $8.96 | $18,475.52 | -3.5% | → |
| 2024-01-23 | Dube Eric M | CHIEF EXECUTIVE OFFICER | Sell | 7,873 | $8.96 | $70,542.08 | -3.2% | → |
| 2024-01-23 | Heerma Peter | CHIEF COMMERCIAL OFFICER | Sell | 1,559 | $9.07 | $14,137.64 | -1.9% | → |
| 2024-01-23 | Calvin Sandra | SVP, CHIEF ACCOUNTING OFFICER | Sell | 910 | $9.07 | $8,252.24 | -2.2% | → |
| 2024-01-23 | ROTE WILLIAM E. | SENIOR VICE PRESIDENT, R&D | Sell | 2,062 | $8.96 | $18,475.52 | -3.3% | → |
| 2024-01-23 | Cline Christopher R. | CHIEF FINANCIAL OFFICER | Sell | 853 | $9.07 | $7,735.35 | -1.7% | → |
| 2024-01-04 | Inrig Jula | Chief Medical Officer | Sell | 2,509 | $9.43 | $23,647.68 | -3.4% | → |
| 2023-10-03 | Heerma Peter | Chief Commercial Officer | Sell | 3,091 | $8.25 | $25,504.15 | -3.7% | → |
| 2023-09-05 | Cline Christopher R. | Chief Financial Officer | Sell | 457 | $14.71 | $6,722.56 | -0.9% | → |
| 2023-09-05 | Dube Eric M | Chief Executive Officer | Sell | 4,455 | $14.71 | $65,533.05 | -1.8% | → |
| 2023-09-05 | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sell | 1,815 | $14.71 | $26,698.65 | -3.0% | → |
| 2023-09-05 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 1,815 | $14.71 | $26,698.65 | -2.9% | → |
| 2023-05-11 | Calvin Sandra | SVP, Chief Accounting Officer | Sell | 558 | $16.49 | $9,199.88 | -0.7% | → |
| 2023-05-10 | ROTE WILLIAM E. | Senior Vice President, R&D | Sell | 825 | $16.59 | $13,686.75 | -1.4% | → |
| 2023-05-10 | REED ELIZABETH E | SVP, GC & Corporate Secretary | Sell | 825 | $16.59 | $13,686.75 | -1.4% | → |
| 2023-05-10 | Cline Christopher R. | Chief Financial Officer | Sell | 455 | $16.59 | $7,548.45 | -0.9% | → |
| 2023-04-11 | Cline Christopher R. | Chief Financial Officer | Sell | 47 | $21.49 | $1,010.03 | - | → |
| 2023-02-02 | Calvin Sandra | SVP, Chief Accounting Officer | Sell | 360 | $22.42 | $8,071.20 | -0.8% | → |